[Pilot study on oxaflumazine, a new piperazinated phenothiazine].
D000328:Adult; D014150:Antipsychotic Agents / Q000009:adverse effects / Q000627:therapeutic use*; D001480:Basal Ganglia Diseases / Q000139:chemically induced; D002986:Clinical Trials as Topic; D003702:Delusions / Q000188:drug therapy*; D004147:Dioxins / Q000009:adverse effects / Q000627:therapeutic use; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D010640:Phenothiazines; D010879:Piperazines / Q000009:adverse effects / Q000627:therapeutic use; D011569:Psychiatric Status Rating Scales; D012559:Schizophrenia / Q000188:drug therapy*; D013997:Time Factors
D014150:Antipsychotic Agents; D004147:Dioxins; D010640:Phenothiazines; D010879:Piperazines
Une étude pilote de l'oxaflumazine, une nouvelle phenothiazine pipérazinée.